Site (ICD-10) | 5-year survival rates | ||
---|---|---|---|
observed | relative | age-stand. relative | |
Male | |||
Colorectal (C18-C21) | 49.2 47.2 - 51.0 | 60.4 58.1 - 62.7 | 60.1 54.6 - 65.3 |
Lung (C33, C34) | 13.0 11.8 - 14.2 | 15.5 14.1 - 17.0 | 15.4 12.1 - 19.2 |
Prostate (C61) | 69.8 68.3 - 71.4 | 87.3 85.3 - 89.2 | 86.0 80.5 - 90.9 |
All cancer sites (C00-C97 except C44) | 43.8 43.0 - 44.6 | 52.8 51.8 - 53.7 | 52.2 50.1 - 54.2 |
Female | |||
Colorectal (C18-C21) | 48.1 46.2 - 50.0 | 60.0 57.6 - 62.4 | 61.8 56.4 - 66.6 |
Lung (C33, C34) | 15.8 13.6 - 18.2 | 17.8 15.3 - 20.5 | 16.6 11.8 - 22.5 |
Breast (C50) | 72.5 71.2 - 73.8 | 81.1 79.6 - 82.5 | 79.6 76.1 - 82.8 |
All cancer sites (C00-C97 except C44) | 51.3 50.5 - 52.1 | 59.9 59.0 - 60.9 | 58.3 56.4 - 60.2 |